PDF-VAERSLot-Analysis

PDF-VAERSLot-Analysis

Analysis: VAERS by Lot

Re: a comparison of Adverse Reactions from the Covid Vaccines as reported to VAERS by manufacturer & Lot Number

 

Back to All Cases

The following document was presented in the German Corona Ausschuss (on Jan 7, 2022) by Mike Yeadon (former Pfizer Exec):


Click the “View Fullscreen” button below to get full functionality in fullscreen.


Back to All Cases

Pfizer FOIA Case

Pfizer FOIA Case

Pfizer FOIA Case

Re: the Legality of Pfizer taking 75 years to release the data on its covid vaccine

 

Back to All Cases

Facts of the Case

  • Dates: Jan 6, 2022
  • Location: USA
  • Court: US District Court for the Northern District of Texas, Fort Worth Div.
  • Case #: 4:21-cv-1058-P
  • Plaintiff: PHMPT, Plaintiff
  • Defendant: FDA
  • Trial Type: FOIA Request
  • Judge:
  • Status: Dedided
  • Verdict: for the Plaintiff


 

Background

The Firm of Attorney Aaron Siri, on behalf of Public Health and Medical Professionals for Transparency (PHMPT), and an unnamed client made a request : that the FDA produce all the data submitted by Pfizer to license its Covid-19 vaccine. [1]

The FDA asked the Court for permission to only be required to produce at a rate of 500 pages per month, which would have taken over 75 years to produce all the documents. [1]

 

This case involves the Freedom of Information Act (“FOIA”). Specifically, at issue is Plaintiff’s FOIA request seeking “[a]ll data and information for the Pfizer Vaccine enumerated in 21 C.F.R. § 601.51(e) with the exception of publicly available reports on the Vaccine Adverse Events Reporting System” from the Food and Drug Administration (“FDA”). See ECF No. 1. As has become standard, the Parties failed to agree to a mutually acceptable production schedule; instead, they submitted dueling production schedules for this Court’s consideration. Accordingly, the Court held a conference with the Parties to determine an appropriate production schedule.[1] See ECF Nos. 21, 34. [2]

 

Significance

According to Siri, this case about the importance of transparency and the excessive role of : government federal “health”  authorities have had on the data needed for independent scientists to offer solutions and address serious issues with the current vaccine program – issues which include waning immunity, variants evading vaccine immunity, and, as the CDC has confirmed, that the vaccines do not prevent transmission. [1]

 

Plaintiff’s Argument

The Plaintiff argued that the documents should be made public as it has a right to know what it has bought and paid for.  The issue is about transparency and the ability of scientists and everyone involved in the management of a crisis to have the best information available in order to serve the society as efficiently and usefully as possible. [1]

No person should ever be coerced to engage in an unwanted medical procedure. And while it is bad enough the government violated this basic liberty right by mandating the Covid-19 vaccine, the government also wanted to hide the data by waiting to fully produce what it relied upon to license this product until almost every American alive today is dead. That form of governance is destructive to liberty and antithetical to the openness required in a democratic society. [1]

 

Defendant’s Argument

…More information is needed…

 

Relevant Prior Judgements/ Cases

The Court order discussed the following cases: [2]

  • “[t]he basic purpose of FOIA is to ensure an informed citizenry, [which is] vital to the functioning of a democratic society.” NLRB v. Robbins Tire & Rubber Co., 437 U.S. 214, 242 (1977). “
  • FOIA was [therefore] enacted to ‘pierce the veil of administrative secrecy and to open agency action to the light of public scrutiny.’” Batton v. Evers, 598 F.3d 169, 175 (5th Cir. 2010) (quoting Dep’t of the Air Force v. Rose, 425 U.S. 352, 361 (1976)).
  • And “Congress has long recognized that ‘information is often useful only if it is timely’ and that, therefore ‘excessive delay by the agency in its response is often tantamount to denial.’” Open Soc’y Just. Initiative v. CIA, 399 F. Supp. 3d 161, 165 (S.D.N.Y. 2019) (quoting H.R. REP. NO. 93-876, at 6271 (1974)).
  • When needed, a court “may use its equitable powers to require an agency to process documents according to a court-imposed timeline.” Clemente v. FBI, 71 F. Supp. 3d 262, 269 (D.D.C. 2014).

 

Decision

A federal judge soundly rejected the FDA’s request and ordered the FDA to produce all the data at a clip of 55,000 pages per month! [1]

The Judge recognized that the release of this data is of paramount public importance and should be one of the FDA’s highest priorities. He then aptly quoted James Madison as saying a “popular Government, without popular information, or the means of acquiring it, is but a Prologue to a Farce or a Tragedy” and John F. Kennedy as explaining that a “nation that is afraid to let its people judge the truth and falsehood in an open market is a nation that is afraid of its people.” [1]

According to the order: [2]

“[t]he basic purpose of FOIA is to ensure an informed citizenry, [which is] vital to the functioning of a democratic society.” NLRB v. Robbins Tire & Rubber Co., 437 U.S. 214, 242 (1977). “FOIA was [therefore] enacted to ‘pierce the veil of administrative secrecy and to open agency action to the light of public scrutiny.’”
there may not be a “more important issue at the Food and Drug Administration . . . than the pandemic, the Pfizer vaccine, getting every American vaccinated, [and] making sure that the American public is assured that this was not [] rush[ed] on behalf of the United States . . . .” ECF No. 34 at 46. Accordingly, the Court concludes that this FOIA request is of paramount public importance. [2]
“[S]tale information is of little value.” Payne Enters., Inc. v. United States, 837 F.2d 486, 494 (D.C. Cir. 1988). The Court, agreeing with this truism, therefore concludes that the expeditious completion of Plaintiff’s request is not only practicable, but necessary.[2]
Accordingly, having considered the Parties’ arguments, filings in support, and the applicable law, the Court ORDERS that:
[2]

  1. The FDA shall produce the “more than 12,000 pages” articulated in its own proposal, see ECF No. 29 at 24, on or before January 31, 2022.
  2. The FDA shall produce the remaining documents at a rate of 55,000 pages every 30 days, with the first production being due on or before March 1, 2022, until production is complete.
  3. To the extent the FDA asserts any privilege, exemption, or exclusion as to any responsive record or portion thereof, FDA shall, concurrent with each production required by this Order, produce a redacted version of the record, redacting only those portions as to which privilege, exemption, or exclusion is asserted.
  4. The Parties shall submit a Joint Status Report detailing the progress of the rolling production by April 1, 2022, and every 90 days thereafter.

Aftermath

…More information is needed…

 


Further Research

Court Documents:
In the news:
  • …More information is needed…

other:

 

Media

……

source: ….

….

source: ….

 

References

  1. Court Orders FDA to Produce Pfizer Covid-19 Data at a rate of 500 pages per month
  2. The Judge’s Ruling / Order

 

Keyword

Aaron, Adverse reactions, CDC, Data, FOIA, Informed Citizenry, JFK, Kennedy, License, Madison, Pfizer, Secrecy, Siri, Transparency, Trial, usa, Vaccine, VAERS


Back to All Cases